Le Lézard
Classified in: Health
Subjects: NPT, CSR

Envista Smile Project Donates $1.2 Million in 2023


BREA, Calif., April 11, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") announced today that the Envista Smile Project (Smile Project) donated $1.2 million in 2023 as part of the non-profit's commitment to expanding and improving access to oral health for those in need. 

Donations in 2023, which include contributions from Envista employees, more than doubled over 2022. Since its founding in 2021, the Envista Smile Project has provided more than $2.2 million in value of goods and services and served approximately 19,000 patients in need around the world.

In 2023, the Envista Smile Project:

"We are committed to advancing oral health care to communities that otherwise would not have access to care," said Amir Aghdaei, Envista CEO and Envista Smile Project Chairman. "Oral health is inextricably tied to physical health, and our goal is to improve people's lives through donations and medical mission trips, one smile at a time."

Envista Smile Project is a philanthropic foundation designed to improve the oral health of disadvantaged communities by supporting increased access to oral care and oral health education. The Smile Project's mission is to collaborate with dental professionals and Envista employee volunteers to donate products, treatment, and oral health education to communities in need worldwide.

ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.

FOR FURTHER INFORMATION
Melissa Morrison 
Vice President, Communication & Central Marketing
Envista Holdings Corporation 
200 S. Kraemer Blvd., Building E 
Brea, CA?92821 
Telephone: (714) 817-7000 

SOURCE Envista Holdings Corporation


These press releases may also interest you

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

2 mai 2024
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....



News published on and distributed by: